Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer

http://clinicaltrials.gov/ct2/show/NCT00529100?term=%22Eli+Lilly+and+Company%22&rank=13

This study has been completed and has results

Sponsor: Eli Lilly and Company

Information provided by (Responsible Party): Eli Lilly and Company

ClinicalTrials.gov Identifier: NCT00529100

First received: September 12, 2007

Last updated: July 3, 2013

Last verified: July 2013

Expand All  Collapse All  Edit

Visual Summary created by WebSummarizer